Cargando…
Association between abnormal lipid metabolism and tumor
Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid meta...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248433/ https://www.ncbi.nlm.nih.gov/pubmed/37305043 http://dx.doi.org/10.3389/fendo.2023.1134154 |
_version_ | 1785055373199147008 |
---|---|
author | Li, Chunyu Wang, Fei Cui, Lili Li, Shaoxin Zhao, Junyu Liao, Lin |
author_facet | Li, Chunyu Wang, Fei Cui, Lili Li, Shaoxin Zhao, Junyu Liao, Lin |
author_sort | Li, Chunyu |
collection | PubMed |
description | Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid metabolism is involved in the occurrence, development, invasion, and metastasis of tumors by regulating various oncogenic signal pathways. The differences in lipid metabolism among different tumors are related to various factors such as tumor origin, regulation of lipid metabolism pathways, and diet. This article reviews the synthesis and regulatory pathways of lipids, as well as the research progress on cholesterol, triglycerides, sphingolipids, lipid related lipid rafts, adipocytes, lipid droplets, and lipid-lowering drugs in relation to tumors and their drug resistance. It also points out the limitations of current research and potential tumor treatment targets and drugs in the lipid metabolism pathway. Research and intervention on lipid metabolism abnormalities may provide new ideas for the treatment and survival prognosis of tumors. |
format | Online Article Text |
id | pubmed-10248433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102484332023-06-09 Association between abnormal lipid metabolism and tumor Li, Chunyu Wang, Fei Cui, Lili Li, Shaoxin Zhao, Junyu Liao, Lin Front Endocrinol (Lausanne) Endocrinology Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid metabolism is involved in the occurrence, development, invasion, and metastasis of tumors by regulating various oncogenic signal pathways. The differences in lipid metabolism among different tumors are related to various factors such as tumor origin, regulation of lipid metabolism pathways, and diet. This article reviews the synthesis and regulatory pathways of lipids, as well as the research progress on cholesterol, triglycerides, sphingolipids, lipid related lipid rafts, adipocytes, lipid droplets, and lipid-lowering drugs in relation to tumors and their drug resistance. It also points out the limitations of current research and potential tumor treatment targets and drugs in the lipid metabolism pathway. Research and intervention on lipid metabolism abnormalities may provide new ideas for the treatment and survival prognosis of tumors. Frontiers Media S.A. 2023-05-25 /pmc/articles/PMC10248433/ /pubmed/37305043 http://dx.doi.org/10.3389/fendo.2023.1134154 Text en Copyright © 2023 Li, Wang, Cui, Li, Zhao and Liao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Li, Chunyu Wang, Fei Cui, Lili Li, Shaoxin Zhao, Junyu Liao, Lin Association between abnormal lipid metabolism and tumor |
title | Association between abnormal lipid metabolism and tumor |
title_full | Association between abnormal lipid metabolism and tumor |
title_fullStr | Association between abnormal lipid metabolism and tumor |
title_full_unstemmed | Association between abnormal lipid metabolism and tumor |
title_short | Association between abnormal lipid metabolism and tumor |
title_sort | association between abnormal lipid metabolism and tumor |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248433/ https://www.ncbi.nlm.nih.gov/pubmed/37305043 http://dx.doi.org/10.3389/fendo.2023.1134154 |
work_keys_str_mv | AT lichunyu associationbetweenabnormallipidmetabolismandtumor AT wangfei associationbetweenabnormallipidmetabolismandtumor AT cuilili associationbetweenabnormallipidmetabolismandtumor AT lishaoxin associationbetweenabnormallipidmetabolismandtumor AT zhaojunyu associationbetweenabnormallipidmetabolismandtumor AT liaolin associationbetweenabnormallipidmetabolismandtumor |